Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients	Digestive System Diseases, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, carcinoma, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, head and neck squamous cell carcinoma, intestinal disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm, squamous cell carcinoma	Active, not recruiting	Phase 2	2026-07-08		NCT04291105

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Regeneron Pharmaceuticals	238
Vyriad, Inc.	3

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Billings Clinic Montana Cancer Consortium	Billings	United States	1
Hospital de Amor de Barretos	Barretos	Brazil	3
Hospital Moinhos de Vento	Porto Alegre	Brazil	6
Hospital Sao Rafael	Salvador	Brazil	1
Icahn School of Medicine at Mount Sinai	New York	United States	342
INCA	Rio de Janeiro	Brazil	1
Mayo Clinic	Rochester	United States	664
Ochsner Clinic Foundation	New Orleans	United States	69
Saint John's Health Center - John Wayne Cancer Institute (JWCI)	Santa Monica	United States	2
Sanford Cancer Center	Sioux Falls	United States	12
University of Cincinnati Medical Center	Cincinnati	United States	83
University of Miami	Miami	United States	327
Yale University	New Haven	United States	1